Brief: Atossa Therapeutics Reports Q3 Loss Per Share Of $0.06
07/11/2022 21:54
Nov 7 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* ATOSSA THERAPEUTICS - QTRLY LOSS PER SHARE $0.06
* ATOSSA THERAPEUTICS SAYS AS OF SEPTEMBER 30, COMPANY HAD
CASH,
CASH EQUIVALENTS AND RESTRICTED CASH OF APPROXIMATELY $117,477
Source text for Eikon: ID:nGNX4BxlgL
Further company coverage: ATOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary